PTC THERAPEUTICS, INC. — Director's Dealing 2021

Jan 12, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2021-01-08

Reporting Person: Klein Matthew B. (Chief Development Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-08	Common Stock	M	5500	$38.98	Acquired	24809	Direct
2021-01-08	Common Stock	S	4000	$69.481	Disposed	20809	Direct
2021-01-08	Common Stock	S	1500	$70.324	Disposed	19309	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-08	Stock Option (Right to Buy)	$38.98	M	5500	Disposed	2029-10-24	Common Stock (5500)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$66.49	2031-01-05	Common Stock (52500)	52500	Direct
Stock Option (Right to Buy)	$47.49	2030-04-15	Common Stock (50000)	50000	Direct

Footnotes

F1: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 2, 2020.

F2: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $68.98 to $69.93 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F3: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $70.00 to $70.61 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F4: This option was granted on October 25, 2019, and vests over four years, with 25% of the shares underlying the option vesting on October 28, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on January 28, 2021.

F5: This option was granted on April 16, 2020, and vests over four years, with 25% of the shares underlying the option vesting on April 16, 2021, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on July 16, 2021.

F6: This option was granted on January 6, 2021, and vests over four years, with 25% of the shares underlying the option vesting on January 6, 2022, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 6, 2022.